IRCT20210429051129N1尚未招募3 期
Efficacy of Dalfyra (extended release Fampridine) in fatigue in multiple sclerosis patients
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 88
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Patients with MS over the age of 18 who have not taken Dalfyra for the past year.
- •Patients have The Expanded Disability Status Scale (EDSS) below 7
排除标准
- •Patients have a kidney problem or a history of seizures.
- •Patients who are allergic to this drug.
- •Patients who have had an acute attack in the last 3 months.
研究者
相似试验
招募中
3 期
Dalfampridine in improving spasticity in patients with severe brain traumaSevere traumatic brain injury.Diffuse traumatic brain injuryS06.2IRCT20221108056446N2Esfahan University of Medical Sciences80
招募中
3 期
Effect of Dalfampridine in Treatment of Spinal Cord InjuryThoracic Spinal Cord Injury.Injury of spinal cord, level unspecifiedT09.3IRCT20231019059767N1Mashhad University of Medical Sciences52
进行中（未招募）
1 期
The FENDEEP Study: Fenfluramine for the treatment of different types of developmental and epileptic encephalopathies: a pilot trial exploring epileptic and non-epileptic outcomes. - The FENDEEP StudyEUCTR2021-002821-32-ESeurologia Aplicada, SLP20
已完成
不适用
"Effect examination of infliximab to the effect insufficient example and the example of effect decrease of the 1st TNF inhibitor in rheumatoid arthritis "Rheumatoid ArthritisJPRN-UMIN000007786Saitama Medical Center. Saitama Medical University40
招募中
2 期
Study of addition of fludarabine to the standard regimen of Anti-thymocyte globulin (ATG) and cyclosporine in patients with aplastic anemia (condition that occurs when the body stops producing enough new blood cells)CTRI/2014/06/004676INVESTIGATOR INITIATED STUDY20